About CAIRIBU
Hundreds of millions of people, both nationally and globally, are directly impacted by non-cancerous genitourinary (GU) diseases and disorders. These conditions, including but not limited to UTIs, urolithiasis (kidney stones), urinary incontinence, over/underactive bladder, pelvic pain syndrome, and erectile dysfunction cost over $11.5 billion dollars to treat annually. To improve GU clinical treatment and patient …
